abstract |
The present invention relates to ((S)-2,2-difluorocyclopropyl)-((1R,5S)-3-(2-((1-methyl-1H-pyrazol-4-yl)amino)-pyri Novel crystalline form of midin-4-yl)-3,8-diazabicyclo[3.2.1]octan-8-yl)methanone free base (structure below), pharmaceutical compositions containing same, preparation thereof and its preparation It is about use: . |